PEOPLE LIVING WITH ALS ELIGIBLE FOR COVID-19 VACCINATIONS STARTING FEBRUARY 25 UNDER ILLINOIS PHASE 1B; CHICAGO, COOK COUNTY EXCLUDED

lesturner Foundation Blog, Home Page

We are pleased to announce big changes in access to COVID-19 vaccinations for people living with ALS in Illinois. The State is making plans to expand COVID-19 Phase 1B vaccination eligibility on February 25 to people who have comorbidities and …

February 2021 Events eNews

lesturner ALS Learning Series, Events eNews, Home Page

Hoops & Hope Time to dress in your favorite team’s jersey because the NCAA Bracket Challenge for Charity hosted by the Young ProfessionALS Group is back! The Bracket Challenge is an exciting few weeks about having fun, competing against one …

February 2021 Foundation eNews

lesturner Advocacy, Foundation eNews, Home Page, Research & The Les Turner ALS Center

Therapeutic Potential for New ALS Drug According to a recent study published in JAMA Neurology, ezogabine, an experimental drug, is found to have potential therapeutic possibilities for ALS treatment. “Most importantly, ezogabine decreased cortical and spinal motor neuron excitability in …

Foundation Advocating for COVID-19 Vaccination Prioritization for Individuals with ALS

lesturner Foundation Blog, Home Page

As we turn the calendar to 2021, the Les Turner ALS Foundation is taking proactive steps to help ensure that those living with neuromuscular disease, including ALS, are given priority access to COVID-19 vaccines and treatments. On Wednesday, January 6, Illinois …